Literature DB >> 21217078

The nerve growth factor reduces APOBEC3G synthesis and enhances HIV-1 transcription and replication in human primary macrophages.

Thiago Moreno L Souza1, Diego Q Rodrigues, Caroline P B Passaes, Victor Barreto-de-Souza, Renato S Aguiar, Jairo R Temerozo, Mariza G Morgado, Carlos Frederico L Fontes, Elizabeth G Araujo, Dumith Chequer Bou-Habib.   

Abstract

Macrophages infected with HIV-1 sustain viral replication for long periods of time, functioning as viral reservoirs. Therefore, recognition of factors that maintain macrophage survival and influence HIV-1 replication is critical to understanding the mechanisms that regulate the HIV-1-replicative cycle. Because HIV-1-infected macrophages release the nerve growth factor (NGF), and NGF neutralization reduces viral production, we further analyzed how this molecule affects HIV-1 replication. In the present study, we show that NGF stimulates HIV-1 replication in primary macrophages by signaling through its high-affinity receptor Tropomyosin-related Kinase A (TrKA), and with the involvement of reticular calcium, protein kinase C, extracellular signal-regulated kinase, p38 kinase, and nuclear factor-κB. NGF-induced enhancement of HIV-1 replication occurred during the late events of the HIV-1-replicative cycle, with a concomitant increase in viral transcription and production. In addition, NGF reduced the synthesis of the cellular HIV-1 restriction factor APOBEC3G and also overrode its interferon-γ-induced up-regulation, allowing the production of a well-fitted virus. Because NGF-TrKA signaling is a crucial event for macrophage survival, it is possible that NGF-induced HIV-1 replication plays a role in the maintenance of HIV-1 reservoirs. Our study may contribute to the understanding of the immunopathogenesis of HIV-1 infection and provide insights about approaches aimed at limiting viral replication in HIV-1 reservoirs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21217078     DOI: 10.1182/blood-2010-05-287193

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Suppression of immunodeficiency virus-associated neural damage by the p75 neurotrophin receptor ligand, LM11A-31, in an in vitro feline model.

Authors:  Rick B Meeker; Winona Poulton; Wen-hai Feng; Lola Hudson; Frank M Longo
Journal:  J Neuroimmune Pharmacol       Date:  2011-12-10       Impact factor: 4.147

Review 2.  Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.

Authors:  Belete A Desimmie; Krista A Delviks-Frankenberrry; Ryan C Burdick; DongFei Qi; Taisuke Izumi; Vinay K Pathak
Journal:  J Mol Biol       Date:  2013-11-02       Impact factor: 5.469

Review 3.  Role of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disorders.

Authors:  Jerel Fields; Wilmar Dumaop; T D Langford; Edward Rockenstein; E Masliah
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-08       Impact factor: 4.147

4.  Tissue-specific HIV-1 infection: why it matters.

Authors:  Maile Ay Karris; Davey M Smith
Journal:  Future Virol       Date:  2011-07       Impact factor: 1.831

Review 5.  AID and APOBECs span the gap between innate and adaptive immunity.

Authors:  Arnaud Moris; Shannon Murray; Sylvain Cardinaud
Journal:  Front Microbiol       Date:  2014-10-13       Impact factor: 5.640

Review 6.  Neuroendocrine Control of Macrophage Development and Function.

Authors:  Arnon Dias Jurberg; Vinícius Cotta-de-Almeida; Jairo Ramos Temerozo; Wilson Savino; Dumith Chequer Bou-Habib; Ingo Riederer
Journal:  Front Immunol       Date:  2018-06-25       Impact factor: 7.561

7.  The Neuropeptides Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide Control HIV-1 Infection in Macrophages Through Activation of Protein Kinases A and C.

Authors:  Jairo R Temerozo; Suwellen S D de Azevedo; Daniella B R Insuela; Rhaíssa C Vieira; Pedro L C Ferreira; Vinícius F Carvalho; Gonzalo Bello; Dumith Chequer Bou-Habib
Journal:  Front Immunol       Date:  2018-06-12       Impact factor: 7.561

8.  Macrophage Resistance to HIV-1 Infection Is Enhanced by the Neuropeptides VIP and PACAP.

Authors:  Jairo R Temerozo; Rafael Joaquim; Eduardo G Regis; Wilson Savino; Dumith Chequer Bou-Habib
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

9.  The role of growth factor receptors in viral infections: An opportunity for drug repurposing against emerging viral diseases such as COVID-19?

Authors:  Hubert Hondermarck; Nathan W Bartlett; Victor Nurcombe
Journal:  FASEB Bioadv       Date:  2020-04-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.